DSPS testifies before Congress on prescription drug monitoring program
Wisconsin triumphed its prescription drug monitoring program at a U.S. Senate committee hearing last week, with program staff telling lawmakers that they’ve received interest from other states in mimicking their approach to its revamp.
To access this content, you must purchase a Premium membership, or log in if you are a member.
